Antibody Information
General Information of This Antibody
| Antibody ID | ANTI0YYJIG |
|||||
|---|---|---|---|---|---|---|
| Antibody Name | 230A |
|||||
| Synonyms |
230A
Click to Show/Hide
|
|||||
| Antigen Name | V-type immunoglobulin domain-containing suppressor of T-cell activation (VSIR) |
Antigen Info | ||||
| Click to Show/Hide the Sequence Information of This Antibody | ||||||
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
CN114230664B 230A: DBM- (C6)-MMAF [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | < 0.001 nM | High C10orf54 expression (C10orf54 +++) | ||
| Method Description |
259A: DBM- (C6)-MMAF was tested in P31/FUJ,100-300nm,3days
|
||||
| In Vitro Model | Acute myeloid leukemia, Childhood acute myeloid leukemia | P31/FUJ cells | CVCL_1632 | ||
| Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
1.56 nM
|
High C10orf54 expression (C10orf54 +++) | ||
| Method Description |
259A: DBM- (C6)-MMAF was tested in OCI/AML3,100-300nm,3days
|
||||
| In Vitro Model | Adult acute myelomonocytic leukemia, Acute myelomonocytic leukemia | OCI/AML3 cells | CVCL_1844 | ||
| Experiment 3 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 100 nM | High C10orf54 expression (C10orf54 +++) | ||
| Method Description |
259A: DBM- (C6)-MMAF was tested in PL21,100-300nm,3days
|
||||
| In Vitro Model | Acute promyelocytic leukemia | PL21 cells | CVCL_2161 | ||